Biliary atresia is the first indication for a liver transplant in pediatric patients. It is a degenerative and progressive disease of unknown origin that leads to a progressive destruction of the biliary tract. The direct consequence is the accumulation of bile in the liver no longer discharged into the intestine, with a progressive toxic damage. The transplant currently represents a sound therapy for pediatric patients affected with biliary atresia.
As a Regional reference center for the treatment of rare diseases of the liver and biliary tract of pediatric patients, ISMETT is the identified facility in Sicily also for the treatment of atresia.
ISMETT is one of the largest and most important pediatric liver transplant centers in Europe. Our pediatric transplant program is one of the most recognized for volume of activity and survival rates.
Download our information material to discover the benefits and risks of a liver transplant for pediatric patients affected with biliary atresia, the survival rates, and when to opt for this procedure:
Liver transplant in pediatric patients affected with biliary atresia
Link to an interesting letter published by the newspaper “Corriere della Sera” and the answer by Jean de Ville de Goyet, Director, ISMETT Department for the Treatment and Study of Pediatric Abdominal Diseases and Abdominal Transplantation:
A link to the TV show Le Iene on the story of Lucio, a baby of only a few months transplanted at ISMETT.
See contacts below to reach our pediatricians.
Email: pediatria@ismett.edu
Fax: + 39 091 21 92 400
